Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Roberts

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Biochimica Et Biophysica Acta|August 30, 2000
Role of phosphatidic acid phosphatase 2a in uptake of extracellular lipid phosphate mediatorsR Z Roberts, A J Morris
Expert Opinion on Pharmacotherapy|July 2, 2024
Fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopauseMegan Z Roberts, Miranda R Andrus
Emerging Topics in Life Sciences|November 21, 2022
Translational cognitive systems: focus on attentionBenjamin Z Roberts, Jared W Young
The Journal of the Tennessee Dental Association|March 25, 2016
Pediatricians and the Oral Health Needs of Children: One Potential Means for Reducing Oral Healthcare InequitiesRyan Z Roberts, Paul Campbell Erwin
Cognitive, Affective & Behavioral Neuroscience|March 8, 2024
Decision-making for delaying punishment? A commentary to Minnes et al. (2024)Jared W Young, Benjamin Z Roberts
Expert Opinion on Pharmacotherapy|October 11, 2024
Reply to 'fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopause requiring careful evaluation of the benefit-risk balance'Megan Z Roberts, Miranda R Andrus
Cell Death and Differentiation|December 16, 2021
The role of Ubiquitination in Apoptosis and NecroptosisJamie Z Roberts, Nyree Crawford, Daniel B Longley
Pharmacotherapy|April 1, 2018
Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current LiteratureElizabeth W Covington, Megan Z Roberts, Jenny Dong
Pharmacotherapy|July 26, 2017
Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment: An Alternative ViewpointMegan Z Roberts, T Michael Farley, Ryan E Owens
Vascular Health and Risk Management|December 22, 2018
Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetesJessica W Skelley, Brooke S Carter, Megan Z Roberts
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Biochimica Et Biophysica Acta|August 30, 2000
Role of phosphatidic acid phosphatase 2a in uptake of extracellular lipid phosphate mediatorsR Z Roberts, A J Morris
Expert Opinion on Pharmacotherapy|July 2, 2024
Fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopauseMegan Z Roberts, Miranda R Andrus
Emerging Topics in Life Sciences|November 21, 2022
Translational cognitive systems: focus on attentionBenjamin Z Roberts, Jared W Young
The Journal of the Tennessee Dental Association|March 25, 2016
Pediatricians and the Oral Health Needs of Children: One Potential Means for Reducing Oral Healthcare InequitiesRyan Z Roberts, Paul Campbell Erwin
Cognitive, Affective & Behavioral Neuroscience|March 8, 2024
Decision-making for delaying punishment? A commentary to Minnes et al. (2024)Jared W Young, Benjamin Z Roberts
Expert Opinion on Pharmacotherapy|October 11, 2024
Reply to 'fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopause requiring careful evaluation of the benefit-risk balance'Megan Z Roberts, Miranda R Andrus
Cell Death and Differentiation|December 16, 2021
The role of Ubiquitination in Apoptosis and NecroptosisJamie Z Roberts, Nyree Crawford, Daniel B Longley
Pharmacotherapy|April 1, 2018
Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current LiteratureElizabeth W Covington, Megan Z Roberts, Jenny Dong
Pharmacotherapy|July 26, 2017
Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment: An Alternative ViewpointMegan Z Roberts, T Michael Farley, Ryan E Owens
Vascular Health and Risk Management|December 22, 2018
Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetesJessica W Skelley, Brooke S Carter, Megan Z Roberts
Pageof 5